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Abstract: To date, pulmonary function tests (PFTs) are part of consolidated standard operating procedures 
in thoracic surgery. PFTs are usually used to assess the pre-operative risk, post-operative outcomes and 
complications after pulmonary resections. The only functional parameter used in common practice 
is the forced expiratory volume in one second (FEV1). However, the FEV1 alone poorly reflects lung 
pathophysiology, especially in patients with pre-operative emphysema and airflow obstruction; moreover, 
the predictive power of spirometric parameters in guiding the surgical approach in terms of the extension of 
the excision is currently unknown. In the present critical overview, we report and discuss the results of four 
studies that compared pre and post-surgery FEV1 and forced vital capacity (FVC) in patients undergoing 
lobectomy or segmentectomy, highlighting the critical aspects of spirometry in lung surgery and suggesting 
new approaches for the interpretation of pulmonary mechanics in patients undergoing major or minor 
parenchymal resections. Overall, the literature on the topic is limited to spirometric parameters, and post-
surgical function loss and the consequent recovery are often analysed in inhomogeneous study samples, with 
varying respiratory comorbidities and functional phenotypes. We underline the role of static lung volumes 
in the patients’ initial assessment. In fact, they tend to decrease in patients with emphysema that undergo a 
lobectomy, followed by a decrease in lung compliance; some of these patients experience also an increase in 
closing volume, a condition that worsens the stresses implicated in lung ventilation and promotes the damage 
to the remaining airways. Spirometric data should be therefore always associated to body-plethysmography 
and indexes of ventilation distribution, to improve the evaluation of the functional characteristics in patients 
undergoing lung surgery. Prospective studies are needed to establish the relationship and long-term 
consequences of different surgical approaches in terms of lung mechanics and functional loss. 
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Introduction
Pulmonary function tests (PFTs) are widely used by 
thoracic surgeons to predict post-operative outcomes 
and complications for patients undergoing a pulmonary 
resection. Predicted postoperative forced expiratory volume 
in one second (ppoFEV1) is the most widely used parameter 
to assess the preoperative risk, but a single value of FEV1 
without a correlation to other functional parameters may be 
insufficient and insidious.  
The present critical review will analyze how PFTs 
are currently used in clinical practice and what kind of 
information they may provide to clinicians and surgeons to 
personalize the management of patients undergoing lung 
surgery based on their functional characteristics. 
Thoracic surgery operability criteria: state of the 
art
Every kind of surgical intervention can affect the lung: 
supine position and general anaesthesia produce a headward 
shift of the diaphragm and reduce the vital capacity, the tidal 
volume and the respiratory rate. Cough reflex is abolished 
and atelectasis may occur in depending regions when 
mechanical ventilation is not well titrated. For patients 
undergoing thoracic surgery, lobar or lung resection can 
magnify all the complications from general anaesthesia and 
general surgery. 
British Thoracic Society (BTS) guidelines for lung 
cancer surgery recommend to perform lung function tests 
with lung diffusion capacity for carbon monoxide (DLCO) 
and arterial blood gas analysis in all patients that undergo 
thoracic surgery (1). Patients are defined as operable with 
an average operative risk when FEV1 is >1.5 L (>2 L for 
pneumonectomy) or ppoFEV1 is ≥40%, DLCO is ≥40% 
predicted and oxygen saturation >90%. According to the 
BTS guidelines, when one or more of these criteria are 
not satisfied, additional tests should be performed, e.g., a 
6-minute walk test, a cardiopulmonary exercise test or a 
quantitative perfusion scan. A perfusion scan provides an 
accurate measurement of the ppoFEV1, although the latter 
can be estimated by some mathematic equations (1). The 
exercise test is very useful when spirometric criteria are not 
reached: BTS guidelines identify the peak rate of oxygen 
consumption (VO2) as the most important parameter for 
the operability evaluation. The threshold for VO2 defined 
by guidelines for an “average operative risk” is VO2 
>15 mL/kg/min, otherwise, patients are classified in the 
“high risk” class. 
The choice of the type of intervention, lobectomy vs. 
segmentectomy or other minimal resections, belongs to 
thoracic surgeons and it is not within the scope of the 
present review, which will focus only on the functional 
evaluation of pre-operatory and post-operative lung 
pathophysiology. 
Functional consideration in real life: a literature 
analysis
Guidelines worldwide recommend performing a complete 
bundle of PFTs; nevertheless, in the clinical and surgical 
practice FEV1 is the parameter most frequently used, and 
often the only parameter considered for the indication 
to operate the patient. Ppo-FEV1 has proved to be an 
independent risk factor for post-operatory morbidity 
and mortality, but according to guidelines, all functional 
variables should be considered to assess the phenotype of 
every single patient and to guide clinicians and surgeons 
towards the best management of each cases, “personalizing” 
as much as possible the surgery indication (1). 
The literature comparing lung function after lobectomy 
with minor resections such as segmentectomy is scarce 
and investigations are difficult to compare due to the 
inhomogeneity of the patients enrolled and the variability 
of the lung function parameters reported. The major 
limitations of the studies we report are represented by the 
retrospective design and the lack of patients’ clinical and 
pathophysiological characterization 
Almquist and colleagues enrolled 149 patients and 
studied how preoperative FEV1 and DLCO impacted on 
short- and long-term outcomes after lung surgery for early 
stage non-small cell lung cancer (NSCLC stage I and II) (2). 
Most of the patients underwent lobectomy, but patients 
with wedge resections and pneumonectomy were also 
included. Authors performed a multivariate analysis to study 
predictors of mortality and of length of hospitalization: 
neither FEV1 nor DLCO resulted to be good predicting 
factors for mortality, although they both were independent 
risk factors for the length of hospitalization (in latter case, 
more than 10 days).  
In the study by Almquist et al., the FEV1 to forced 
vital capacity (FVC) ratio was not reported, therefore it 
was not possible to verify if this cohort of patients had an 
obstructive, a restrictive or a normal lung function pattern. 
In a prospective study of patients with early stage 
NSCLC and a good operatory risk, Takizawa and colleagues 
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enrolled 184 patients: 133 underwent lobectomy and 51 
segmentectomy (3). The aim of the study was to investigate 
the post-operative functional advantage of performing 
segmentectomy and wedge resection compared with 
lobectomy. PFTs were performed at baseline (pre-operatory) 
and then 2 weeks and 12 months after the resection. Pre-
operative FVC and FEV1 were not significantly different 
between the two groups and the mean FEV1/FVC ratio 
that could be inferred from the available data was generally 
within normal range, allowing us to speculate that the basal 
and pre-operative functional pattern of the study sample 
was normal. 
Nevertheless, no significant difference in absolute FVC 
value was observed between the two groups either 2 weeks 
or 12 months after the surgery (mean ± standard deviation; 
segmentectomy vs. lobectomy: 2.05±0.66 vs. 1.91±0.51 liters, 
P=0.3 and 2.67±0.73 vs. 2.57±0.59 liters, P=0.5 respectively 
after 2 weeks and 12 months), but while the total loss in 
FVC after 12 months in the lobectomy group was 280 mL, 
patients that underwent segmentectomy lost 140 mL (3). 
Considering the post-operative FEV1 value, the between 
group difference both at 2 weeks and 12 months was of 
40 mL; however, 2 weeks after surgery, the total loss of 
FEV1 in the lobectomy group was of 750 mL, while in the 
segmentectomy group was of 590 mL; the total re-gain in 
FEV1 12 months after the intervention was comparable, 
around 450 mL, without reaching the pre-surgery value (3). 
Unfortunately, the authors did not compare the pre and 
post-surgery parameters after 2 weeks and 12 months, 
thus the presence of a significant difference between the 
two approaches cannot be inferred. However, in this 
study the segmentectomy procedure seems to give a 
functional advantage both for FVC and FEV1, although 
the comparison between the two groups did not reach a 
statistical difference. In a retrospective study conducted 
by Deng and co-workers, lobectomy and segmentectomy 
procedures were compared in terms of 5 years overall 
survival, disease-free survival and post-operative lung 
function in early stage NSCLC patients (4). The advantage 
of different surgical approaches in terms of post-surgery 
survival still represents an open issue and will not be the 
subject of the present review. 
The lung function parameters reported were the mean 
FEV1, FVC and DLCO, performed at baseline (pre-
operatory) and within 24 months after surgery. No FEV1/
FVC ratio was reported. The most frequent comorbidity 
was COPD, 43.6% and 60.8% in patients treated with 
lobectomy and segmentectomy, respectively. At the end 
of the follow-up period, the surgical approach appeared 
not to have influenced the post-operative lung function, 
with no difference in FVC, FEV1 and DLCO in patients 
that underwent lobectomy or segmentectomy. Conversely, 
Kashiwabara and colleagues compared pre-operative and 
6 months post-operative FEV1 in patients with early stage 
NSCLC that underwent lobectomy or segmentectomy (5). 
In their study, patients were stratified in two groups: 
patients with a ppoFEV1 <70% and with a ppoFEV1 ≥70% 
of predicted value.
In patients  with ppoFEV1 <70%, there was no 
significant difference in the total loss of FEV1 between 
the segmentectomy and the lobectomy group; vice versa, 
in patients with a preserved ppoFEV1, the ΔFEV1 after 
the surgery was smaller in the segmentectomy group, 
suggesting a functional advantage over lobectomy (5). 
Functional considerations 
None of the cited studies reported the FEV1/FVC, the 
parameter that is essential to phenotype the functional 
pattern of the patients enrolled, if obstructive, restrictive 
or normal. A thorough pre-operative patients’ functional 
evaluation represents a step of paramount importance 
in view of the selection of the best surgical approach 
and strategy, to drive and the best pre- and post-surgical 
management of patients with lung cancer. 
In Takizawa’s study, the loss of FVC and FEV1 12 months 
after a lobectomy is almost twice as much as compared 
with segmentectomy (mean loss in FVC at 12 months: 
−140 and −280 mL; mean loss in FEV1: −140 and −300 mL, 
for segmentectomy and lobectomy, respectively) (3). 
The FVC depends on the lung-chest wall compliance and 
airways size: when a larger anatomic part is removed, more 
parenchyma and elastic fibres are lost and a bigger scar 
is performed. Thus, less amount of FVC lost in patients 
undergoing a segmentectomy might be explained by the 
minor resection and a reduced loss in lung compliance. 
This is sustained by the measurements of lung mechanics 
performed by Berend and colleagues in patients treated with 
lobectomy (6).
Patients undergoing segmentectomy appeared to have 
also a functional advantage in terms of post-operative 
FEV1. The latter may be justified by the size and number 
of resected airways, so that the total size of the airways 
could have an impact on the resulting FEV1. However, the 
reviewed studies show contrasting results in terms of FEV1 
post-surgical loss and recovery due to important differences 
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in the baseline patients characteristics. All considered, the 
isolated FEV1 value seems not to be a good predictor of the 
lung function trajectory in patients undergoing lobectomy 
and segmentectomy. 
When the loss of FEV1 and FVC is analysed 2 weeks 
after the surgery and then after 12 months, there is a re-
gain of about 650 mL in FVC and 450 mL in FEV1 for 
both the surgical approaches. The stress applied by surgery 
to the chest wall (rib-cage and thoracic muscles) and to the 
pleura and lung appears to impact the thoraco-pulmonary 
system compliance, such as the elastic properties are 
“paralyzed” and then resumed after 12 months. Considering 
an unaltered total lung capacity (TLC) after the surgical 
intervention, with no scarring tissue to create an extra-
pulmonary restrictive pattern per se, the lung parenchyma 
re-expands to fill the room left in the chest cavity. However, 
we may expect that the mechanics of the respiratory system 
could adapt differently, for any given different pre-operative 
parenchymal condition (presence of emphysema, flow 
limitation, fibrosis etc.) and depending on the regional 
distribution of the parenchymal disease.
In the study by Kashiwabara and colleagues (5) the 
majority of the study sample is represented by smokers, 
while the 16% of the patients in the lobectomy arm and 
20% of the segmentectomy arm had emphysema. The 
authors observe that only patients without pre-procedural 
airflow obstruction (a ppoFEV1 <70% of the predicted 
value) exposed to lobectomy suffer from a reduction in 
FEV1 and FVC after surgery. These findings deserve a 
short pathophysiological parenthesis to explain the possible 
effects of lung surgery on lung mechanics, especially in 
patients with airflow obstruction. Patients with COPD 
are characterized by maldistribution of ventilation with 
impaired gas exchange and peripheral lung injury, these 
abnormalities due to the presence of closing volume, 
the lung volume at which some regions of the lung 
stop contributing to lung deflation and trap air beyond 
functionally closed airways (7). Roughly half of patients 
with COPD independently of disease severity, experience a 
cyclic opening and closure of the small airways during tidal 
breathing because the closing volume exceeds the functional 
residual capacity (8), a phenomenon which can be partially 
reversed by the administration of bronchodilators (9). 
When patients with COPD undergo a lung excision—
e.g., a lobectomy—all static lung volumes tend to decrease 
(TLC, FRC and residual volume), together with a decrease 
in lung compliance (6); due to the reduction of FRC, 
some of these patients experience also an increase in 
closing volume (6), a condition that worsens the stresses 
implicated in lung ventilation and promotes the damage to 
the remaining airways (10,11). In the study by Kashiwabara 
and coworkers, the majority of patients with emphysema 
had an upper lobe distribution of the disease, with the 
lobectomy mostly directed to upper lobes. We can speculate 
that the removal of an emphysematous parenchyma may 
have caused a partial improvement of the regional lung 
volume distribution and ventilation inhomogeneity, thus 
explaining the lack of difference in lung function loss 
compared with patients with a preserved FEV1. The type 
and extent of lung resection should therefore be carefully 
studied and personalized in view of the pathophysiological 
characterisation of each patient, that should be as complete 
as possible, including static, dynamic lung volumes and 
ventilation inhomogeneity. In Figure 1, we report a proposal 
for a schematic approach to lobectomy and segmentectomy 
depending on the presence and distribution of emphysema. 
DLCO represents a very important parameter to 
assess patients’ operability: as discussed before, according 
to BTS guidelines patients are classified in the “average 
risk” class when DLCO is ≥40% predicted value (1). As 
it happens for static volumes, patients may have different 
causes for a reduction in pre-operative DLCO [ventilation 
inhomogeneity vs. vascular/epithelial or alveolar damage (12)], 
which may have a different impact on their exercise capacity 
and gas exchange before and after surgery (6). Therefore, 
the type of surgical approach should also rely on a careful 
evaluation of the DLCO pattern. Not surprisingly, the pre-
operative DLCO has been demonstrated to predict the risk 
of complications, short and long-term outcomes and the 
length of hospitalization in patients that underwent thoracic 
surgery (2). 
In conclusion, the isolated value of FEV1 is not a 
reliable parameter to guide the selection of patients for 
lung surgery. Spirometric data should be always associated 
to other lung function parameters such as static volumes, 
airway resistances and indexes of ventilation distribution, 
in order to improve the pathophysiological assessment 
and the careful evaluation of the functional pattern in 
patients undergoing procedures. Specifically, designed and 
prospective studies are needed to establish the relationship 
and long-term consequences of different surgical 
approaches in terms of lung mechanics and functional loss.
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Figure 1 Schematic proposal of different surgical approaches in case of non-diseased lung and and in case of inhomogeneous (upper lobe 
prevalence) emphysema and homogeneous emphysema. Depending on the site and the extension of the surgical excision, some patients will 
benefit (e.g., lobectomy of an emphysematous parenchyma) or will suffer further mechanical stress (e.g., a lobectomy or a segmentectomy of 
parenchyma with/without emphysema in an otherwise homogeneous emphysema). Lung compliance will be affected accordingly. CL, lung 
compliance.
Normal Inhomogeneous
emphysema
Pre op. → Normal CL Pre op. → Slightly increased CL Pre op. → Very increased CL
Pre op. → Reduced CL
Long term → ~Normal CL
Post op. → Reduced CL
Long term → ~Normal CL
Post op. → Very reduced CL
Long term → Slight increase CL
Segmentectomy
Lobectomy
Post op. → Reduced CL
Long term → Increased CL
Post op. → Reduced CL
Long term → Very increased CL
Homogeneous
emphysema
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